from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0555/menD

LFCtreatmentdescriptionclass of inhibitor

-0.712

Amikacinug/mL Amikacintranslation

-0.968

Cap5-10ug/mL Capreomycintranslation

-1.108

Rox10-50 ug/mL Roxithromycintranslation

-0.396

SM2-5 ug/mL Streptomycintranslation

-1.335

Tet5-10 ug/mL Tetracyclinetranslation

1.031

Rif0.2-5ug/mL Rifampicintranscription

0.054

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.316

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-4.385

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.253

CPZ10-50 ug/mL Chlorpromazinerespiration

0.327

Clofazimine10-13 ug/mL Clofaziminerespiration

0.424

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.450

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-3.232

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.270

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.267

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.049

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.766

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.669

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.124

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.617

KCN5-20 ug/mL Potassium cyaniderespiration

-0.222

NaN30.2-2 mM Sodium aziderespiration

-0.153

Nigericin50 uM Nigericinrespiration

-0.202

TRC10-150 ug/mL Triclosanrespiration

-0.782

TRZ10-25 ug/mL Thioridazinerespiration

-1.360

Valinomycin0.5-10 uM Valinomycinrespiration

1.001

ZnSO42 mM ZnSO4respiration

-0.462

menadione6-10 ug/mL Menadionerespiration

0.053

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.121

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.163

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.648

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.728

NRP_1Non-replicating persistence stage 1dosRassociated

0.127

Amp0.2mg/mL AmpicillincellWall

0.091

Cephalexin20-100 ug/mL CephalexincellWall

-0.027

Cerulenin0.32-5 ug/mL CerulenincellWall

1.160

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.580

EMB10-20 ug/mL EthambutolcellWall

-0.015

Eta12-40 ug/mL EthionamidecellWall

-0.002

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.086

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.626

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.131

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.027

BZA0.12 mg/mL BenzamidearomaticAmides

0.645

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.354

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.007

H2O24 mM hydrogen peroxideDNAdamaging

-0.021

Levo10 ug/mL LevofloxacinDNAdamaging

0.450

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.512

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.521

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.442

UVUV-irradiationDNAdamaging

-0.736

ARP41-4 ug/mL Antitubercular compound ARP4?

0.348

Antimycin12.5-50 ug/mL Antimycin A?

0.369

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.278

PA_110-50 ug/mL Antitubercular compound PA-1?

0.156

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.097

PA8240.2-2 ug/mL PA-824?

-0.918

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.109

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.348

Verapamil50 uM Verapamil?

-0.140

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.032

methoxatin10-20 ug/mL Methoxatin?